Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chaperone protein DnaK is the primary bacterial homolog of the eukaryotic 70 kDa heat shock protein (Hsp70) and serves as a central hub in the bacterial molecular chaperone network [6, 7]. It plays a critical role in protein homeostasis by facilitating the folding of nascent polypeptides, refolding misfolded proteins, and solubilizing protein aggregates, particularly under stress conditions such as heat shock or antibiotic exposure [1, 8, 11]. DnaK functions through an ATP-dependent cycle of substrate binding and release, regulated by co-chaperones DnaJ and the nucleotide exchange factor GrpE [3, 5, 9]. Beyond its role in proteostasis, DnaK is essential for bacterial virulence, biofilm formation, and the development of multi-drug resistance in various pathogens [3, 6, 7, 9]. Interestingly, certain bacterial DnaK proteins, such as those from Mycoplasma, have been implicated in oncogenesis by interfering with the p53 tumor suppressor pathway in host cells [4, 16]. As a therapeutic target, DnaK is being targeted by novel proline-rich antimicrobial peptides (PrAMPs) like Api88 and ARV-1502, which selectively inhibit its activity without affecting human Hsp70, as well as small molecule allosteric inhibitors [6, 10, 13, 16].
Inhibition of ATPase activity, prevention of chaperone-assisted protein folding, and disruption of co-chaperone interactions.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chaperone protein DnaK (DnaK) (DnaK).